speb/financial-data huggingface dataset:
Financial ratios for SXI — annual report dated 2025-06-30
Total revenue: 790107000
Gross profit: 315248000
Operating income: 121886000
Net income: 57684000
Capital expenditures: 28343000
Operating cash flow: 69595000
Depreciation & amortization: 35438000
Net tangible assets: -124418000
Owner earnings: 64779000
Return on net tangible assets (%): -52.06561751515054
Capex to operating income (%): 23.253696076661797
Buffett classification: The Great
Stock price: 155.59
P/E ratio: 32.67735791519312
Shares outstanding: 12114922
Book value: 739590000
P/B ratio: 2.548656301437283
Market cap (USD): 1884960713.98
Debt to equity: 0.8162644167714544
Current ratio: 2.8799460997155264
Quick ratio: 2.1014223686180564
Effective tax rate (%): 16.108123819212324
Interest coverage ratio: 5.093226359115791
COGS to revenue (%): 60.10059397018378
SG&A to revenue (%): 24.472887849367236
Free cash flow (dilution-adjusted): 32561000
Buyback yield (%): 0.5255281941173181
Retained earnings: 1126851000
Inventory turnover: 3.652930135237011
Receivables turnover: 3.4066614926917604
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.706733671213405
FCF margin (%): 4.121087397023441
Revenue growth (%): 9.640386603481652
Rule of 40 score: 13.761474000505093
Financial ratios for SXI — quarterly report dated 2025-09-30
Total revenue: 217431000
Gross profit: 90433000
Operating income: 36064000
Net income: 15795000
Capital expenditures: 6420000
Operating cash flow: 16826000
Depreciation & amortization: 9817000
Net tangible assets: -110428000
Owner earnings: 19192000
Return on net tangible assets (%): -17.379650088745606
Capex to operating income (%): 17.801685891748004
Buffett classification: The Great
Stock price: 211.05
P/E ratio: 47.34301642564853
Shares outstanding: 12114922
Book value: 734808000
P/B ratio: 3.479622279697554
Market cap (USD): 2556854288.1
Debt to equity: 0.809408716290514
Current ratio: 2.8731975226432995
Quick ratio: 2.073083201235143
Effective tax rate (%): 24.610473150045266
Interest coverage ratio: 4.046678635547576
COGS to revenue (%): 58.40841462348975
SG&A to revenue (%): 25.005174055217516
Free cash flow (dilution-adjusted): 8632000
Buyback yield (%): 0.14635171106213812
Retained earnings: 1138071000
Inventory turnover: 0.9353425101453118
Receivables turnover: 0.9416469976830298
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6035849828937594
FCF margin (%): 3.969995078898593
Revenue growth (%): -2.0797211426306808
Rule of 40 score: 1.8902739362679122
Financial ratios for SXI — quarterly report dated 2025-12-31
Total revenue: 221320000
Gross profit: 92233000
Operating income: 36628000
Net income: 20681000
Capital expenditures: 7664000
Operating cash flow: 20558000
Depreciation & amortization: 9984000
Net tangible assets: -105896000
Owner earnings: 23001000
Return on net tangible assets (%): -21.7203671526781
Capex to operating income (%): 20.923883367915256
Buffett classification: The Great
Stock price: 216.72
P/E ratio: 35.15351724293059
Shares outstanding: 12114922
Book value: 744747000
P/B ratio: 3.5254199021144093
Market cap (USD): 2625545895.84
Debt to equity: 0.7861340831181596
Current ratio: 2.8729984953954415
Quick ratio: 2.1049125046104127
Effective tax rate (%): 24.05682947476904
Interest coverage ratio: 4.628253727571392
COGS to revenue (%): 58.32595337068498
SG&A to revenue (%): 25.124254473161034
Free cash flow (dilution-adjusted): 9830000
Buyback yield (%): 0.002132889776892806
Retained earnings: 1136096000
Inventory turnover: 0.9839248147809384
Receivables turnover: 0.9240841412597807
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6471208910653528
FCF margin (%): 4.441532622447135
Revenue growth (%): 1.7886133991933073
Rule of 40 score: 6.230146021640443
Financial ratios for TARS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.5
Shares outstanding: 43631052
Market cap (USD): 981698670
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TARS — annual report dated 2022-12-31
Total revenue: 25816000
Gross profit: 24861000
Operating income: -62712000
Net income: -62091000
Capital expenditures: 506000
Operating cash flow: -49030000
Depreciation & amortization: 326000
Net tangible assets: 192900000
Owner earnings: -62271000
Return on net tangible assets (%): -32.28149300155521
Buffett classification: The Gruesome
Stock price: 14.66
Shares outstanding: 43631052
Book value: 192900000
P/B ratio: 3.31586947807154
Market cap (USD): 639631222.32
Debt to equity: 0.10448418869880767
Current ratio: 14.607233132412988
Quick ratio: 14.607233132412988
Interest coverage ratio: -30.38372093023256
COGS to revenue (%): 3.699256275178184
R&D to revenue (%): 165.10691044313603
SG&A to revenue (%): 174.1129532073133
Free cash flow (dilution-adjusted): -62996000
Buyback yield (%): 0
Retained earnings: -108763000
Receivables turnover: 7.2071468453378005
Capitalized R&D asset: 42624000
ROCI (R&D-adjusted, %): -13.446353378447254
FCF margin (%): -244.01921289123024
Rule of 40 score: -244.01921289123024
Financial ratios for TARS — annual report dated 2023-12-31
Total revenue: 17447000
Gross profit: 15854000
Operating income: -143158000
Net income: -135893000
Capital expenditures: 1502000
Operating cash flow: -117493000
Depreciation & amortization: 877000
Net tangible assets: 193121000
Owner earnings: -136518000
Return on net tangible assets (%): -70.6903961764904
Buffett classification: The Gruesome
Stock price: 20.25
Shares outstanding: 43631052
Book value: 196988000
P/B ratio: 4.485190991329421
Market cap (USD): 883528803
Debt to equity: 0.15339513066785795
Current ratio: 6.934454191033138
Quick ratio: 6.8503357158327915
Interest coverage ratio: -44.390077519379844
COGS to revenue (%): 9.13050954318794
R&D to revenue (%): 288.3704934945836
SG&A to revenue (%): 623.0297472344816
Free cash flow (dilution-adjusted): -142825000
Buyback yield (%): 0
Retained earnings: -244656000
Inventory turnover: 0.5127132281943998
Receivables turnover: 0.9849271762447781
Capitalized R&D asset: 78870080
ROCI (R&D-adjusted, %): -40.277997704893394
Rosenberg metric: -0.21131287537537538
FCF margin (%): -818.6221126841291
Revenue growth (%): -32.41788038425783
Rule of 40 score: -851.0399930683869
Financial ratios for TARS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.89
Shares outstanding: 43631052
Market cap (USD): 1435025300.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TARS — annual report dated 2024-12-31
Total revenue: 182953000
Gross profit: 170127000
Operating income: -120569000
Net income: -115554000
Capital expenditures: 1567000
Operating cash flow: -83027000
Depreciation & amortization: 1225000
Net tangible assets: 216208000
Owner earnings: -115896000
Return on net tangible assets (%): -53.60393694960408
Buffett classification: The Gruesome
Stock price: 55.37
Shares outstanding: 43631052
Book value: 224534000
P/B ratio: 10.75940102274043
Market cap (USD): 2415851349.24
Debt to equity: 0.3226816428692314
Current ratio: 4.42496154418697
Quick ratio: 4.392460179625862
Interest coverage ratio: -16.19027796428092
COGS to revenue (%): 7.010543691549195
R&D to revenue (%): 29.18017195673206
SG&A to revenue (%): 129.71090935923434
Free cash flow (dilution-adjusted): -117412000
Buyback yield (%): 0
Retained earnings: -360210000
Inventory turnover: 4.895419847328244
Receivables turnover: 3.806841590544955
Capitalized R&D asset: 101160960
ROCI (R&D-adjusted, %): -29.16864005319113
Rosenberg metric: 3.066326124980124
FCF margin (%): -64.17604521379808
Revenue growth (%): 948.6215395196883
Rule of 40 score: 884.4454943058903
Financial ratios for TARS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 55.37
Shares outstanding: 43631052
Market cap (USD): 2415851349.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TARS — quarterly report dated 2025-03-31
Total revenue: 78335000
Gross profit: 73124000
Operating income: -26280000
Net income: -25120000
Capital expenditures: 590000
Operating cash flow: -20651000
Depreciation & amortization: 460000
Net tangible assets: 334372000
Owner earnings: -25250000
Return on net tangible assets (%): -7.551469620662017
Buffett classification: The Gruesome
Stock price: 51.37
Shares outstanding: 43631052
Book value: 342458000
P/B ratio: 6.544823427223192
Market cap (USD): 2241327141.24
Debt to equity: 0.21131934426995427
Current ratio: 5.570433795244937
Quick ratio: 5.539092552254716
Interest coverage ratio: -12.671166827386692
COGS to revenue (%): 6.652198889385333
R&D to revenue (%): 18.394076721771878
SG&A to revenue (%): 108.50194676709006
Free cash flow (dilution-adjusted): -28171000
Buyback yield (%): 0
Retained earnings: -385330000
Inventory turnover: 1.9264325323475047
Receivables turnover: 1.2210652658488301
Capitalized R&D asset: 14409000
ROCI (R&D-adjusted, %): -3.8880636864552023
FCF margin (%): -35.962213569924046
Rule of 40 score: -35.962213569924046
Financial ratios for TARS — quarterly report dated 2025-06-30
Total revenue: 102660000
Gross profit: 96423000
Operating income: -22184000
Net income: -20340000
Capital expenditures: 1001000
Operating cash flow: -29387000
Depreciation & amortization: 453000
Net tangible assets: 324766000
Owner earnings: -20888000
Return on net tangible assets (%): -6.431707752658837
Buffett classification: The Gruesome
Stock price: 40.51
Shares outstanding: 43631052
Book value: 332612000
P/B ratio: 5.3139812048873765
Market cap (USD): 1767493916.52
Debt to equity: 0.21780933941048428
Current ratio: 5.256656288433626
Quick ratio: 5.213743587470777
Interest coverage ratio: -10.594078319006686
COGS to revenue (%): 6.075394506136762
R&D to revenue (%): 15.189947399181767
SG&A to revenue (%): 100.34385349698032
Free cash flow (dilution-adjusted): -38621000
Buyback yield (%): 0
Retained earnings: -405670000
Inventory turnover: 1.6103795507358636
Receivables turnover: 1.704183266932271
Capitalized R&D asset: 25248030
ROCI (R&D-adjusted, %): -3.8584705288876786
Rosenberg metric: 1.6169755014227218
FCF margin (%): -37.62030001948178
Revenue growth (%): 31.05253079721708
Rule of 40 score: -6.567769222264701
Financial ratios for TARS — quarterly report dated 2025-09-30
Total revenue: 118697000
Gross profit: 110388000
Operating income: -14529000
Net income: -12585000
Capital expenditures: 1910000
Operating cash flow: 18257000
Depreciation & amortization: 460000
Net tangible assets: 327476000
Owner earnings: -14035000
Return on net tangible assets (%): -4.285810257850957
Buffett classification: The Gruesome
Stock price: 59.43
Shares outstanding: 43631052
Book value: 335082000
P/B ratio: 7.738384694970186
Market cap (USD): 2592993420.36
Debt to equity: 0.2159501256408879
Current ratio: 4.286236651003844
Quick ratio: 4.253464331482273
Interest coverage ratio: -6.866257088846881
COGS to revenue (%): 7.00017692106793
R&D to revenue (%): 13.71896509600074
SG&A to revenue (%): 91.52126843980892
Free cash flow (dilution-adjusted): 4104000
Buyback yield (%): 0
Retained earnings: -418255000
Inventory turnover: 2.1660583941605838
Receivables turnover: 1.596763344812742
Capitalized R&D asset: 31486950
ROCI (R&D-adjusted, %): -3.0454482030485885
Rosenberg metric: 0.8955367449018854
FCF margin (%): 3.457543156103356
Revenue growth (%): 15.621468926553671
Rule of 40 score: 19.079012082657027
Financial ratios for TARS — annual report dated 2025-12-31
Total revenue: 451360000
Gross profit: 420676000
Operating income: -70969000
Net income: -66418000
Capital expenditures: 9859000
Operating cash flow: -12451000
Depreciation & amortization: 1816000
Net tangible assets: 336060000
Owner earnings: -74461000
Return on net tangible assets (%): -22.157055287746235
Buffett classification: The Gruesome
Stock price: 81.88
Shares outstanding: 43631052
Book value: 343426000
P/B ratio: 10.402562816327244
Market cap (USD): 3572510537.7599998
Debt to equity: 0.210927536063082
Current ratio: 3.8526253730793325
Quick ratio: 3.820406057702937
Interest coverage ratio: -8.507432270438743
COGS to revenue (%): 6.798121233605105
R&D to revenue (%): 14.250708968450903
SG&A to revenue (%): 94.6745391705069
Free cash flow (dilution-adjusted): -64030000
Buyback yield (%): 0
Retained earnings: -426628000
Inventory turnover: 7.018298261665142
Receivables turnover: 5.181554144807081
Capitalized R&D asset: 116693580
ROCI (R&D-adjusted, %): -11.535102210612392
Rosenberg metric: 4.693159255235455
FCF margin (%): -14.18601559730592
Revenue growth (%): 146.70817095100927
Rule of 40 score: 132.52215535370334
Financial ratios for TARS — quarterly report dated 2025-12-31
Total revenue: 151668000
Gross profit: 140741000
Operating income: -7976000
Net income: -8373000
Capital expenditures: 6358000
Operating cash flow: 19330000
Depreciation & amortization: 443000
Net tangible assets: 336060000
Owner earnings: -14288000
Return on net tangible assets (%): -4.251621734214128
Buffett classification: The Gruesome
Stock price: 81.88
Shares outstanding: 43631052
Book value: 343426000
P/B ratio: 10.402562816327244
Market cap (USD): 3572510537.7599998
Debt to equity: 0.210927536063082
Current ratio: 3.8526253730793325
Quick ratio: 3.820406057702937
Interest coverage ratio: -3.8756073858114672
COGS to revenue (%): 7.204552047894085
R&D to revenue (%): 11.891104254028537
SG&A to revenue (%): 86.16319856528733
Free cash flow (dilution-adjusted): -1342000
Buyback yield (%): 0
Retained earnings: -426628000
Inventory turnover: 2.4993138151875574
Receivables turnover: 1.7411289304205075
Capitalized R&D asset: 34091300
ROCI (R&D-adjusted, %): -1.4284236770054404
Rosenberg metric: 1.8639769098501597
FCF margin (%): -0.884827386132869
Revenue growth (%): 27.7774501461705
Rule of 40 score: 26.892622760037632
Financial ratios for TSD.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5039370078740157
Shares outstanding: 66678963
Market cap (USD): 33601997.1023622
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSD.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -895515.4411764705
Net income: -1485086.7647058822
Capital expenditures: 94476.47058823529
Operating cash flow: 21180.147058823528
Depreciation & amortization: 0
Net tangible assets: 2300760.2941176468
Owner earnings: -1579563.2352941174
Return on net tangible assets (%): -68.65396796583227
Buffett classification: The Gruesome
Stock price: 0.14705882352941177
Shares outstanding: 66678963
Book value: 2300760.294117647
P/B ratio: 4.261951963449422
Market cap (USD): 9805729.852941176
Debt to equity: 0.518262185709711
Current ratio: 0.036658422993738726
Quick ratio: 0.036658422993738726
Free cash flow (dilution-adjusted): -320318.38235294115
Buyback yield (%): 0
Retained earnings: -39095797.058823526
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.78685369097422
Rule of 40 score: 0
Financial ratios for TSD.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -32607.575757575756
Operating income: -918708.3333333333
Net income: -872239.3939393939
Capital expenditures: 117478.78787878787
Operating cash flow: -442263.63636363635
Depreciation & amortization: 32607.575757575756
Net tangible assets: 1752542.424242424
Owner earnings: -957110.606060606
Return on net tangible assets (%): -54.61269255575017
Buffett classification: The Gruesome
Stock price: 0.1818181818181818
Shares outstanding: 66678963
Book value: 1752542.4242424238
P/B ratio: 6.917634432400376
Market cap (USD): 12123447.818181816
Debt to equity: 0.8391535933077314
Current ratio: 0.012007724199215496
Quick ratio: 0.012007724199215496
Free cash flow (dilution-adjusted): -723228.7878787878
Buyback yield (%): 0
Retained earnings: -41152757.57575757
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -52.297056440257904
Rule of 40 score: 0
Financial ratios for TSD.V — quarterly report dated 2024-09-30
Gross profit: 0
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.11851851851851851
Shares outstanding: 66678963
Market cap (USD): 7902691.911111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSD.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -321738.46153846156
Net income: -292837.06293706293
Capital expenditures: 44895.8041958042
Operating cash flow: -66358.74125874125
Depreciation & amortization: 11240.55944055944
Net tangible assets: 1156493.0069930071
Owner earnings: -326492.30769230775
Return on net tangible assets (%): -28.231239248148942
Buffett classification: The Gruesome
Stock price: 0.1118881118881119
Shares outstanding: 66678963
Book value: 1156493.006993007
P/B ratio: 6.451040540336261
Market cap (USD): 7460583.272727273
Debt to equity: 1.3819837524224734
Current ratio: 0.008842955746146259
Quick ratio: 0.008842955746146259
Free cash flow (dilution-adjusted): -137283.21678321678
Buyback yield (%): 0
Retained earnings: -38716700.6993007
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -27.820182188132076
Rule of 40 score: 0
Financial ratios for TSD.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -11240.55944055944
Operating income: -767653.1468531468
Net income: -729539.8601398602
Capital expenditures: 130113.98601398602
Operating cash flow: -372971.32867132867
Depreciation & amortization: 11240.55944055944
Net tangible assets: 1156493.0069930071
Owner earnings: -848413.2867132868
Return on net tangible assets (%): -73.3608661343524
Buffett classification: The Gruesome
Stock price: 0.1118881118881119
Shares outstanding: 66678963
Book value: 1156493.006993007
P/B ratio: 6.451040540336261
Market cap (USD): 7460583.272727273
Debt to equity: 1.3819837524224734
Current ratio: 0.008842955746146259
Quick ratio: 0.008842955746146259
Free cash flow (dilution-adjusted): -628786.0139860141
Buyback yield (%): 0
Retained earnings: -38716700.6993007
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -66.37767303488664
Rule of 40 score: 0
Financial ratios for TSD.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -2751.7482517482517
Operating income: -204784.6153846154
Net income: -201588.1118881119
Capital expenditures: 20777.622377622378
Operating cash flow: -137213.2867132867
Depreciation & amortization: 2751.7482517482517
Net tangible assets: 1077607.6923076923
Owner earnings: -219613.98601398602
Return on net tangible assets (%): -20.379771560806475
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 66678963
Book value: 1077607.692307692
P/B ratio: 5.19246242810577
Market cap (USD): 5595437.454545455
Debt to equity: 1.5994416536500504
Current ratio: 0.011446262902737656
Quick ratio: 0.011446262902737656
Free cash flow (dilution-adjusted): -184441.95804195805
Buyback yield (%): 0
Retained earnings: -38918288.81118881
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.003633404478588
Rule of 40 score: 0
Financial ratios for TSD.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -2977.3722627737225
Operating income: -112202.1897810219
Net income: -2346956.204379562
Capital expenditures: 32129.927007299266
Operating cash flow: 12886.131386861312
Depreciation & amortization: 2977.3722627737225
Net tangible assets: -1248613.1386861312
Owner earnings: -2376108.7591240876
Buffett classification: The Gruesome
Stock price: 0.08029197080291971
Shares outstanding: 66678963
Book value: -1248613.1386861312
Market cap (USD): 5353785.3503649635
Debt to equity: -1.4582859815269498
Current ratio: 0.0227305270850903
Quick ratio: 0.0227305270850903
Free cash flow (dilution-adjusted): -53023.35766423357
Buyback yield (%): 0
Retained earnings: -42969695.62043795
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TSD.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -2870.5035971223024
Operating income: -141063.309352518
Net income: -123207.19424460432
Capital expenditures: 39574.82014388489
Operating cash flow: -89126.61870503597
Depreciation & amortization: 5798.561151079137
Net tangible assets: -1252751.0791366908
Owner earnings: -156983.45323741008
Buffett classification: The Gruesome
Stock price: 0.10071942446043167
Shares outstanding: 66678963
Book value: -1252751.0791366908
Market cap (USD): 6715866.776978418
Debt to equity: -1.4850872095026542
Current ratio: 0.023599014192541085
Quick ratio: 0.023599014192541085
Free cash flow (dilution-adjusted): -147287.76978417268
Buyback yield (%): 0
Retained earnings: -42474633.81294964
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBI.PA — annual report dated 2022-03-31
Operating income: 268333333.3333333
Capital expenditures: 74444444.44444445
Capex to operating income (%): 27.743271221532094
Buffett classification: The Good
Stock price: 44.38888888888889
Shares outstanding: 135945254
Market cap (USD): 6034458774.777779
Buyback yield (%): 2.1542942764537703
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBI.PA — annual report dated 2023-03-31
Total revenue: 1972065217.3913043
Gross profit: 1736739130.4347825
Operating income: -572608695.6521739
Net income: -537173913.0434783
Capital expenditures: 52391304.347826086
Operating cash flow: 749565217.3913044
Depreciation & amortization: 1399021739.1304348
Net tangible assets: -697934782.6086956
Owner earnings: 809456521.7391304
Buffett classification: The Gruesome
Stock price: 26.58695652173913
Shares outstanding: 135945254
Book value: 1611630434.7826085
P/B ratio: 2.2426795122681598
Market cap (USD): 3614370557.4347825
Debt to equity: 1.6604842517029743
Current ratio: 2.7825145486534035
Quick ratio: 2.757477331167952
Interest coverage ratio: -14.633333333333333
COGS to revenue (%): 11.938488673317533
R&D to revenue (%): 79.39150085432398
SG&A to revenue (%): 35.534365871134874
Free cash flow (dilution-adjusted): -481195652.173913
Buyback yield (%): 0
Retained earnings: -537173913.0434783
Inventory turnover: 11.708108108108108
Receivables turnover: 6.762206485277674
Capitalized R&D asset: 1565652173.9130435
ROCI (R&D-adjusted, %): 8.068549162680169
FCF margin (%): -24.400595270903377
Rule of 40 score: -24.400595270903377
Financial ratios for UBI.PA — annual report dated 2024-03-31
Total revenue: 2474086021.5053763
Gross profit: 2254516129.032258
Operating income: 337419354.83870965
Net income: 169784946.23655912
Capital expenditures: 29569892.47311828
Operating cash flow: -422903225.8064516
Depreciation & amortization: 834516129.032258
Net tangible assets: -591827956.9892473
Owner earnings: 974731182.7956989
Return on net tangible assets (%): -164.69840116279067
Capex to operating income (%): 8.763543658381135
Buffett classification: The Great
Stock price: 21.195652173913043
P/E ratio: 16.971164890340614
Shares outstanding: 135945254
Book value: 2020645161.2903228
P/B ratio: 1.4260041167437114
Market cap (USD): 2881448318.478261
Debt to equity: 1.3353554704129413
Current ratio: 2.1680378250591015
Quick ratio: 2.1597163120567373
Effective tax rate (%): 38.02042419481539
Interest coverage ratio: 4.195187165775401
COGS to revenue (%): 8.874788126385328
R&D to revenue (%): 46.54700334651658
SG&A to revenue (%): 30.614107523143115
Free cash flow (dilution-adjusted): -611935483.8709677
Buyback yield (%): 0
Retained earnings: 169677419.3548387
Inventory turnover: 23.204545454545453
Receivables turnover: 3.083489681050657
Capitalized R&D asset: 2200599859.7475457
ROCI (R&D-adjusted, %): 8.87707735673888
Rosenberg metric: 0.3307101074074406
FCF margin (%): -24.73379981746273
Revenue growth (%): 25.456602534583382
Rule of 40 score: 0.7228027171206506
Financial ratios for UBI.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -602000000
Buffett classification: The Gruesome
Stock price: 11.222222222222221
Shares outstanding: 135945254
Book value: 1888777777.7777781
P/B ratio: 0.8077222574269073
Market cap (USD): 1525607850.4444444
Debt to equity: 1.3772574857344548
Current ratio: 2.319954292243965
Quick ratio: 2.2898157406084847
Buyback yield (%): 0
Retained earnings: -274111111.1111111
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBI.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -935543478.2608695
Buffett classification: The Gruesome
Stock price: 12.119565217391305
Shares outstanding: 135945254
Book value: 1862391304.3478255
P/B ratio: 0.8846676678533912
Market cap (USD): 1647597371.8478262
Debt to equity: 1.264328236255399
Current ratio: 1.4317574417104413
Quick ratio: 1.4239240622984057
Buyback yield (%): 0
Retained earnings: -264673913.04347825
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UBI.PA — annual report dated 2025-03-31
Total revenue: 1940543478.2608695
Gross profit: 1720217391.3043478
Operating income: -195543478.26086956
Net income: -264347826.0869565
Capital expenditures: 45543478.26086956
Operating cash flow: 183478260.86956522
Depreciation & amortization: 772500000
Net tangible assets: -935543478.2608695
Owner earnings: 462608695.65217394
Buffett classification: The Gruesome
Stock price: 12.119565217391305
Shares outstanding: 135945254
Book value: 1862391304.3478255
P/B ratio: 0.8846676678533912
Market cap (USD): 1647597371.8478262
Debt to equity: 1.264328236255399
Current ratio: 1.4317574417104413
Quick ratio: 1.4239240622984057
Interest coverage ratio: -1.6923800564440263
COGS to revenue (%): 11.353834089508766
R&D to revenue (%): 59.989917660897326
SG&A to revenue (%): 36.72211953173136
Free cash flow (dilution-adjusted): 78695652.17391305
Buyback yield (%): 0
Retained earnings: -264673913.04347825
Inventory turnover: 23.847058823529412
Receivables turnover: 6.033457249070632
Capitalized R&D asset: 2452376297.3352036
ROCI (R&D-adjusted, %): -5.170575261883444
Rosenberg metric: -0.4639568871026672
FCF margin (%): 4.055340839074666
Revenue growth (%): -21.56523817712162
Rule of 40 score: -17.509897338046954
Financial ratios for UBI.PA — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -1009764705.882353
Buffett classification: The Gruesome
Stock price: 11.447058823529412
Shares outstanding: 135945254
Book value: 1842823529.4117646
P/B ratio: 0.8444505371680286
Market cap (USD): 1556173319.317647
Debt to equity: 1.3333758937691522
Current ratio: 1.1849457881567975
Quick ratio: 1.173999165971643
Buyback yield (%): 0
Retained earnings: -189764705.88235295
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VMO — annual report dated 2022-02-28
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.03
Shares outstanding: 67440684
Market cap (USD): 608989376.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VMO — annual report dated 2023-02-28
Total revenue: -111694373
Net income: -112118963
Capital expenditures: 0
Operating cash flow: 154119729
Net tangible assets: 715008097
Owner earnings: -112118963
Return on net tangible assets (%): -15.68079626936029
Buffett classification: The Gruesome
Stock price: 7.58
Shares outstanding: 67440684
Book value: 715008097
P/B ratio: 0.7149574765165212
Market cap (USD): 511200384.72
Debt to equity: 0.14976753473044935
Free cash flow (dilution-adjusted): 154119729
Buyback yield (%): 0.529335673618896
Retained earnings: -132942071
Receivables turnover: -5.212437502432516
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VMO — annual report dated 2024-02-29
Total revenue: 57624618
Net income: 57178074
Capital expenditures: 0
Operating cash flow: 53910821
Net tangible assets: 743517136
Owner earnings: 57178074
Return on net tangible assets (%): 7.690216032895844
Buffett classification: The Gruesome
Stock price: 8.07
P/E ratio: 9.518444428191128
Shares outstanding: 67440684
Book value: 743517136
P/B ratio: 0.7319889394990353
Market cap (USD): 544246319.88
Debt to equity: 0.08020662485444048
COGS to revenue (%): 0
SG&A to revenue (%): 0.7217106411013432
Free cash flow (dilution-adjusted): 53910821
Buyback yield (%): 0.14065634842855484
Retained earnings: -103667515
Receivables turnover: 4.714700669136027
Capitalized R&D asset: 0
FCF margin (%): 93.5551902487232
Rule of 40 score: 93.5551902487232
Financial ratios for VMO — quarterly report dated 2024-08-31
Capital expenditures: 0
Net tangible assets: 740994499
Buffett classification: The Gruesome
Stock price: 8.71
Shares outstanding: 67440684
Book value: 740994499
P/B ratio: 0.7927297145022396
Market cap (USD): 587408357.6400001
Debt to equity: 0.1155339211229421
Buyback yield (%): 0
Retained earnings: -106190152
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VMO — annual report dated 2025-02-28
Total revenue: 24463243
Net income: 23656426
Capital expenditures: 0
Operating cash flow: 90853212
Net tangible assets: 721448778
Owner earnings: 23656426
Return on net tangible assets (%): 3.279016712119235
Buffett classification: The Gruesome
Stock price: 8.93
P/E ratio: 25.458000634584444
Shares outstanding: 67440684
Book value: 721448778
P/B ratio: 0.834772095379445
Market cap (USD): 602245308.12
Debt to equity: 0.10549605505049452
COGS to revenue (%): 0
SG&A to revenue (%): 3.13763796566138
Free cash flow (dilution-adjusted): 90853212
Buyback yield (%): 12.176713045539898
Retained earnings: -107602190
Receivables turnover: 2.0252224324167476
Capitalized R&D asset: 0
FCF margin (%): 371.3866227793265
Revenue growth (%): -57.547236148272596
Rule of 40 score: 313.8393866310539
Financial ratios for VMO — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 721448778
Buffett classification: The Gruesome
Stock price: 8.93
Shares outstanding: 67440684
Book value: 721448778
P/B ratio: 0.834772095379445
Market cap (USD): 602245308.12
Debt to equity: 0.10549605505049452
Buyback yield (%): 0
Retained earnings: -107602190
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VMO — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: 651027354
Buffett classification: The Gruesome
Stock price: 8.65
Shares outstanding: 67440684
Book value: 651027354
P/B ratio: 0.8960636031892449
Market cap (USD): 583361916.6
Debt to equity: 0.18633625646396418
Buyback yield (%): 0
Retained earnings: -178023614
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRNS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 48.78
Shares outstanding: 114814150
Market cap (USD): 5600634237
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRNS — annual report dated 2022-12-31
Total revenue: 473634000
Gross profit: 403798000
Operating income: -121228000
Net income: -124518000
Capital expenditures: 11375000
Operating cash flow: 11871000
Depreciation & amortization: 12176000
Net tangible assets: 476202000
Owner earnings: -123717000
Return on net tangible assets (%): -25.979941285420892
Buffett classification: The Gruesome
Stock price: 23.94
Shares outstanding: 114814150
Book value: 502125000
P/B ratio: 5.474036845407021
Market cap (USD): 2748650751
Debt to equity: 0.6302454568085636
Current ratio: 3.959277442369821
Quick ratio: 3.959277442369821
Interest coverage ratio: -38.27849700031576
COGS to revenue (%): 14.744718495716103
R&D to revenue (%): 37.556636559030814
SG&A to revenue (%): 73.293935823864
Free cash flow (dilution-adjusted): -142387000
Buyback yield (%): 2.053516620089505
Retained earnings: -543474000
Receivables turnover: 3.3085396947364742
Capitalized R&D asset: 177881000
ROCI (R&D-adjusted, %): -0.2659629827335567
FCF margin (%): -30.06266442020632
Rule of 40 score: -30.06266442020632
Financial ratios for VRNS — annual report dated 2023-12-31
Total revenue: 499160000
Gross profit: 427409000
Operating income: -117223000
Net income: -100916000
Capital expenditures: 5099000
Operating cash flow: 59416000
Depreciation & amortization: 11703000
Net tangible assets: 465250000
Owner earnings: -94312000
Return on net tangible assets (%): -20.271252015045675
Buffett classification: The Gruesome
Stock price: 45.28
Shares outstanding: 114814150
Book value: 489648000
P/B ratio: 10.617391906022286
Market cap (USD): 5198784712
Debt to equity: 0.63686362448126
Current ratio: 2.5006910534653723
Quick ratio: 2.5006910534653723
Interest coverage ratio: -36.66656240225211
COGS to revenue (%): 14.374348906162352
R&D to revenue (%): 36.82947351550605
SG&A to revenue (%): 72.28023078772338
Free cash flow (dilution-adjusted): -85502000
Buyback yield (%): 0.8371571898244053
Retained earnings: -644390000
Receivables turnover: 2.7051516892294685
Capitalized R&D asset: 303018270
ROCI (R&D-adjusted, %): -4.904602713954704
Rosenberg metric: 0.1327348058533514
FCF margin (%): -17.129177017389214
Revenue growth (%): 5.389393497933003
Rule of 40 score: -11.73978351945621
Financial ratios for VRNS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.5
Shares outstanding: 114814150
Market cap (USD): 6486999475
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRNS — annual report dated 2024-12-31
Total revenue: 550950000
Gross profit: 457103000
Operating income: -117651000
Net income: -95765000
Capital expenditures: 6694000
Operating cash flow: 115200000
Depreciation & amortization: 11126000
Net tangible assets: 432521000
Owner earnings: -91333000
Return on net tangible assets (%): -21.11643134090599
Buffett classification: The Gruesome
Stock price: 44.43
Shares outstanding: 114814150
Book value: 455656000
P/B ratio: 11.195271618282213
Market cap (USD): 5101192684.5
Debt to equity: 1.655648120511965
Current ratio: 1.2369242905541038
Quick ratio: 1.2369242905541038
Interest coverage ratio: -25.73856924086633
COGS to revenue (%): 17.033669116979762
R&D to revenue (%): 35.71376712950359
SG&A to revenue (%): 68.6067701243307
Free cash flow (dilution-adjusted): -24829000
Buyback yield (%): 0
Retained earnings: -740155000
Receivables turnover: 2.306339870649057
Capitalized R&D asset: 378637190
ROCI (R&D-adjusted, %): -8.030393838653309
Rosenberg metric: 0.16152264493739052
FCF margin (%): -4.5065795444232695
Revenue growth (%): 10.375430723615674
Rule of 40 score: 5.868851179192404
Financial ratios for VRNS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.43
Shares outstanding: 114814150
Market cap (USD): 5101192684.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRNS — quarterly report dated 2025-03-31
Total revenue: 136423000
Gross profit: 107405000
Operating income: -43766000
Net income: -35783000
Capital expenditures: 2339000
Operating cash flow: 68000000
Depreciation & amortization: 2419000
Net tangible assets: 321979000
Owner earnings: -35703000
Return on net tangible assets (%): -11.088611369064443
Buffett classification: The Gruesome
Stock price: 40.45
Shares outstanding: 114814150
Book value: 367743000
P/B ratio: 12.629016371487698
Market cap (USD): 4644232367.5
Debt to equity: 2.0183035435072862
Current ratio: 1.1520641930523243
Quick ratio: 1.1520641930523243
COGS to revenue (%): 21.270606862479198
R&D to revenue (%): 39.73670128937203
SG&A to revenue (%): 70.63178496294613
Free cash flow (dilution-adjusted): 33081000
Buyback yield (%): 1.3191415750150879
Retained earnings: -775938000
Receivables turnover: 1.1039335162123014
Capitalized R&D asset: 54210000
ROCI (R&D-adjusted, %): -0.827836855566025
FCF margin (%): 24.248843670055635
Rule of 40 score: 24.248843670055635
Financial ratios for VRNS — quarterly report dated 2025-06-30
Total revenue: 152163000
Gross profit: 120914000
Operating income: -36552000
Net income: -35824000
Capital expenditures: 3377000
Operating cash flow: 21349000
Depreciation & amortization: 2569000
Net tangible assets: 295905000
Owner earnings: -36632000
Return on net tangible assets (%): -12.379648873793954
Buffett classification: The Gruesome
Stock price: 50.75
Shares outstanding: 114814150
Book value: 341499000
P/B ratio: 17.062474890116807
Market cap (USD): 5826818112.5
Debt to equity: 2.173534915182768
Current ratio: 1.3849698858436241
Quick ratio: 1.3849698858436241
COGS to revenue (%): 20.536529905430363
R&D to revenue (%): 36.964965201790186
SG&A to revenue (%): 66.52011329955376
Free cash flow (dilution-adjusted): -16537000
Buyback yield (%): 0.6647882129167799
Retained earnings: -811762000
Receivables turnover: 1.0164325364221158
Capitalized R&D asset: 92567700
ROCI (R&D-adjusted, %): -1.8291321011722403
Rosenberg metric: 0.24919756502490314
FCF margin (%): -10.867950815901368
Revenue growth (%): 11.537643945668986
Rule of 40 score: 0.6696931297676176
Financial ratios for VRNS — quarterly report dated 2025-09-30
Total revenue: 161577000
Gross profit: 126428000
Operating income: -35934000
Net income: -29942000
Capital expenditures: 2971000
Operating cash flow: 33398000
Depreciation & amortization: 2976000
Net tangible assets: 452327000
Owner earnings: -29937000
Return on net tangible assets (%): -6.618441967868378
Buffett classification: The Gruesome
Stock price: 57.47
Shares outstanding: 114814150
Book value: 604835000
P/B ratio: 10.909370655633355
Market cap (USD): 6598369200.5
Debt to equity: 0.8459745219770681
Current ratio: 1.8074121143871271
Quick ratio: 1.8074121143871271
COGS to revenue (%): 21.75371494705311
R&D to revenue (%): 38.827927242119856
SG&A to revenue (%): 61.65790923213081
Free cash flow (dilution-adjusted): -2657000
Buyback yield (%): 0
Retained earnings: -841704000
Receivables turnover: 1.1328561011863028
Capitalized R&D asset: 118311790
ROCI (R&D-adjusted, %): -2.4714891280968594
Rosenberg metric: 0.09803189503440184
FCF margin (%): -1.6444172128458878
Revenue growth (%): 6.186786538120305
Rule of 40 score: 4.542369325274418
Financial ratios for VRNS — annual report dated 2025-12-31
Total revenue: 623532000
Gross profit: 491558000
Operating income: -146514000
Net income: -129324000
Capital expenditures: 12628000
Operating cash flow: 147431000
Depreciation & amortization: 12309000
Net tangible assets: 446693000
Owner earnings: -129643000
Return on net tangible assets (%): -29.022841190705922
Buffett classification: The Gruesome
Stock price: 32.8
Shares outstanding: 114814150
Book value: 598656000
P/B ratio: 6.290597805751549
Market cap (USD): 3765904119.9999995
Debt to equity: 0.8715305617917468
Current ratio: 1.9706217552890402
Quick ratio: 1.9706217552890402
Interest coverage ratio: -22.30724725943971
COGS to revenue (%): 21.1655536524188
R&D to revenue (%): 38.139822815829824
SG&A to revenue (%): 64.19205429713311
Free cash flow (dilution-adjusted): 1668000
Buyback yield (%): 3.053715557686583
Retained earnings: -869479000
Receivables turnover: 2.1550148614087234
Capitalized R&D asset: 430313090
ROCI (R&D-adjusted, %): -7.347494855125289
Rosenberg metric: 0.17510736157345055
FCF margin (%): 0.2675083235503551
Revenue growth (%): 13.173972229784917
Rule of 40 score: 13.441480553335273
Financial ratios for VRNS — quarterly report dated 2025-12-31
Total revenue: 173369000
Gross profit: 136811000
Operating income: -30262000
Net income: -27775000
Capital expenditures: 3941000
Operating cash flow: 24684000
Depreciation & amortization: 4345000
Net tangible assets: 446693000
Owner earnings: -27371000
Return on net tangible assets (%): -6.127474574260174
Buffett classification: The Gruesome
Stock price: 32.8
Shares outstanding: 114814150
Book value: 598656000
P/B ratio: 6.290597805751549
Market cap (USD): 3765904119.9999995
Debt to equity: 0.8715305617917468
Current ratio: 1.9706217552890402
Quick ratio: 1.9706217552890402
COGS to revenue (%): 21.086814828487217
R&D to revenue (%): 37.27309957374156
SG&A to revenue (%): 59.0953399973467
Free cash flow (dilution-adjusted): -12219000
Buyback yield (%): 0.3983107249156413
Retained earnings: -869479000
Receivables turnover: 0.5991878067325638
Capitalized R&D asset: 125215300
ROCI (R&D-adjusted, %): -2.1340302997322804
Rosenberg metric: 0.1655004223982658
FCF margin (%): -7.047972820977222
Revenue growth (%): 7.298068413202374
Rule of 40 score: 0.25009559222515243
Financial ratios for VSTD — annual report dated 2022-12-31
Total revenue: 8282368
Gross profit: 166095
Operating income: -3784230
Net income: -3487367
Capital expenditures: 1473275
Operating cash flow: -3798770
Depreciation & amortization: 658371
Net tangible assets: 5637843
Owner earnings: -4302271
Return on net tangible assets (%): -76.31058544908043
Buffett classification: The Gruesome
Stock price: 3.42
Shares outstanding: 14124980
Book value: 5637843
P/B ratio: 8.568424413379372
Market cap (USD): 48307431.6
Debt to equity: 1.7080699125534358
Current ratio: 3.119912899683665
Quick ratio: 3.089266249784866
Interest coverage ratio: -42.85651189127973
COGS to revenue (%): 97.99459526550861
SG&A to revenue (%): 36.62520187463296
Free cash flow (dilution-adjusted): -5272045
Buyback yield (%): 0
Retained earnings: -6300409
Inventory turnover: 133.27432305949193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.971349315832484
FCF margin (%): -63.653836680524215
Revenue growth (%): 26.70256464151973
Rule of 40 score: -36.951272039004486
Financial ratios for VSTD — annual report dated 2023-12-31
Total revenue: 9214779
Gross profit: 364394
Operating income: -3515254
Net income: -3040364
Capital expenditures: 1471151
Operating cash flow: -4591656
Depreciation & amortization: 545549
Net tangible assets: 2653479
Owner earnings: -3965966
Return on net tangible assets (%): -149.46287496528143
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 14124980
Book value: 2653479
P/B ratio: 7.239542050266839
Market cap (USD): 19209972.8
Debt to equity: 3.6376296929427365
Current ratio: 0.46966069757055545
Quick ratio: 0.4473230836999015
Interest coverage ratio: -16.113709185754953
COGS to revenue (%): 96.04554813522928
SG&A to revenue (%): 38.41554962956789
Free cash flow (dilution-adjusted): -6062807
Buyback yield (%): 0
Retained earnings: -9340773
Inventory turnover: 121.19996439477973
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.05276307282316
FCF margin (%): -65.79438313170614
Revenue growth (%): 11.257782798349456
Rule of 40 score: -54.53660033335669
Financial ratios for VSTD — quarterly report dated 2024-09-30
Total revenue: 3015525
Gross profit: -41063
Operating income: -1049045
Net income: -1222116
Capital expenditures: 38401
Operating cash flow: 543261
Depreciation & amortization: 259650
Net tangible assets: -2889950
Owner earnings: -1000867
Buffett classification: The Gruesome
Stock price: 1.88
Shares outstanding: 14124980
Book value: -399806
Market cap (USD): 26554962.4
Debt to equity: -39.49098812924268
Current ratio: 0.3117735757262398
Quick ratio: 0.2965978106742649
Interest coverage ratio: -6.496761048355133
COGS to revenue (%): 101.3617197668731
SG&A to revenue (%): 31.768332214125234
Free cash flow (dilution-adjusted): 504860
Buyback yield (%): 0
Retained earnings: -12543910
Inventory turnover: 34.16632760278107
Receivables turnover: 82.85092177926752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.188431761390605
FCF margin (%): 16.742026678604887
Rule of 40 score: 16.742026678604887
Financial ratios for VSTD — annual report dated 2024-12-31
Total revenue: 12839137
Gross profit: 1516475
Operating income: -2555029
Net income: -2665869
Capital expenditures: 761527
Operating cash flow: 875224
Depreciation & amortization: 862146
Net tangible assets: -2221469
Owner earnings: -2565250
Buffett classification: The Gruesome
Stock price: 0.82
Shares outstanding: 14124980
Book value: 255399
P/B ratio: 45.35054405068148
Market cap (USD): 11582483.6
Debt to equity: 60.28314128089773
Current ratio: 0.2424344352483468
Quick ratio: 0.2193554837546674
Interest coverage ratio: -5.612685183557985
COGS to revenue (%): 88.18865317816922
SG&A to revenue (%): 30.623047327869468
Free cash flow (dilution-adjusted): 113697
Buyback yield (%): 0
Retained earnings: -12006642
Inventory turnover: 81.21144439184634
Receivables turnover: 152.64697420045178
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.155651964065413
FCF margin (%): 0.8855501736604259
Revenue growth (%): 39.33201219475801
Rule of 40 score: 40.217562368418434
Financial ratios for VSTD — quarterly report dated 2024-12-31
Total revenue: 3686607
Gross profit: 1110305
Operating income: 213280
Net income: 537268
Capital expenditures: 324485
Operating cash flow: -289495
Depreciation & amortization: 238893
Net tangible assets: -2221469
Owner earnings: 451676
Return on net tangible assets (%): -20.33231163702937
Capex to operating income (%): 152.1403788447112
Buffett classification: The Gruesome
Stock price: 0.82
P/E ratio: 5.389527945085135
Shares outstanding: 14124980
Book value: 255399
P/B ratio: 45.35054405068148
Market cap (USD): 11582483.6
Debt to equity: 60.28314128089773
Current ratio: 0.2424344352483468
Quick ratio: 0.2193554837546674
Effective tax rate (%): 0.1486800924790175
Interest coverage ratio: 5.123720751453418
COGS to revenue (%): 69.8827404168657
SG&A to revenue (%): 24.331994161569163
Free cash flow (dilution-adjusted): -613980
Buyback yield (%): 0
Retained earnings: -12006642
Inventory turnover: 18.478446730071294
Receivables turnover: 43.830781119961955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8494339793778747
FCF margin (%): -16.654338257373244
Revenue growth (%): 22.25423433730445
Rule of 40 score: 5.599896079931206
Financial ratios for VSTD — quarterly report dated 2025-03-31
Total revenue: 3511789
Gross profit: 94501
Operating income: -1273597
Net income: -1424886
Capital expenditures: 32622
Operating cash flow: -863204
Depreciation & amortization: 240323
Net tangible assets: 1680911
Owner earnings: -1217185
Return on net tangible assets (%): -72.41222170596777
Buffett classification: The Gruesome
Stock price: 3.07
Shares outstanding: 14124980
Book value: 4144503
P/B ratio: 10.462940574539335
Market cap (USD): 43363688.599999994
Debt to equity: 3.0982322850291095
Current ratio: 0.6513471473324267
Quick ratio: 0.6254258037044922
Interest coverage ratio: -3.731091821518865
COGS to revenue (%): 97.30903536630476
SG&A to revenue (%): 37.75693813039451
Free cash flow (dilution-adjusted): -895826
Buyback yield (%): 0
Retained earnings: -13431528
Inventory turnover: 23.866909715674566
Receivables turnover: 60.82178423595836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.460212492798604
FCF margin (%): -25.509106612043038
Revenue growth (%): -4.7419754804349905
Rule of 40 score: -30.25108209247803
Financial ratios for ZDC.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3228346456692913
Shares outstanding: 110927729
Market cap (USD): 35811314.08661417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZDC.V — annual report dated 2022-12-31
Total revenue: 16249264.705882352
Gross profit: 7921323.529411764
Operating income: 3014705.8823529407
Net income: 4410294.117647058
Capital expenditures: 6443382.352941176
Operating cash flow: 4551470.5882352935
Depreciation & amortization: 2463235.2941176468
Net tangible assets: 6241911.7647058815
Owner earnings: 430147.05882352963
Return on net tangible assets (%): 6.891271056661566
Capex to operating income (%): 213.73170731707322
Buffett classification: The Gruesome
Stock price: 0.4411764705882352
P/E ratio: 11.09647172390797
Shares outstanding: 110927729
Book value: 6241911.7647058815
P/B ratio: 7.840338956296383
Market cap (USD): 48938703.97058823
Debt to equity: 2.436093768406173
Current ratio: 1.0220897140533949
Quick ratio: 0.8438812847269279
Effective tax rate (%): -50.21287252692211
Interest coverage ratio: 3.9690222652468536
COGS to revenue (%): 51.25118783655369
SG&A to revenue (%): 24.820127607584052
Free cash flow (dilution-adjusted): -2152205.8823529407
Buyback yield (%): 0.05859671029594414
Retained earnings: -79316911.76470588
Inventory turnover: 8.612927756653992
Receivables turnover: 4.228664370455415
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.270486924084285
FCF margin (%): -13.244943210100002
Rule of 40 score: -13.244943210100002